Samra, V., Flach, J., Naumann, N., Brendel, S., Kleiner, H., Weiß, C., . . . Popp, H. (2019). Antileukemic efficacy in vitro of talazoparib and APE1 inhibitor III combined with decitabine in myeloid malignancies. Cancers, 11(10), . https://doi.org/10.3390/cancers11101493
Chicago-Zitierstil (17. Ausg.)Samra, Vanessa, et al. "Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies." Cancers 11, no. 10 (2019). https://doi.org/10.3390/cancers11101493.
MLA-Zitierstil (9. Ausg.)Samra, Vanessa, et al. "Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies." Cancers, vol. 11, no. 10, 2019, https://doi.org/10.3390/cancers11101493.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.